[1]Patent:WO2006/67401,2006,A1.Locationinpatent:Page/Pagecolumn190-191
[1]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.1711-1714
[1]EuropeanJournalofMedicinalChemistry,2020,vol.197
141943-04-6
19867-34-6
2937-99-7
4727-72-4
67686-01-5
134575-07-8
877383-76-1 | 4-Bromo-2-fluoro-N-isopropylbenzamide | AA004LL5 | MFCD09949819
852026-79-0 | 1-(4-Bromo-3-methylphenylsulfonyl)pyrrolidine | AA004MD9 | MFCD04966262
87411-30-1 | 4-(4-tert-Butyl-phenoxy)-butyric acid | AA004N2Z | MFCD02730396
876710-70-2 | 1-Isopropyl-2,3-dihydro-1h-indole-5-carbaldehyde | AA004NXG | MFCD07186368
871332-76-2 | 4-Chloro-3-(dimethylaminocarbonyl)phenylboronic acid | AA004OQ8 | MFCD07783868
850568-19-3 | Ethyl 3-(4-boronobenzamido)propionate | AA004P99 | MFCD04115673
849021-33-6 | 2-(1,3-Benzoxazol-2-yl)-1-(4-tert-butylphenyl)ethanone | AA004PZ3 | MFCD04037909
864466-71-7 | (S)-2-(((tert-Butyldimethylsilyl)oxy)diphenylmethyl)pyrrolidine | AA004QS3 | MFCD09954370
83417-23-6 | 5-(Pyridin-2-yl)-4H-1,2,4-triazol-3-amine | AA004RQJ | MFCD00160310
850567-95-2 | 4-Boronobenzohydrazide | AA004SFL | MFCD06659865